Sign In
Buy CRL
$232.51
-2.11 (-0.90%)
At Close: Jul 31, 2026
Avidity Partners Management LP Buys New Shares in Charles River Laboratories International, Inc. $CRL
04:05am, Saturday, 01'st Aug 2026
Avidity Partners Management LP bought a new position in shares of Charles River Laboratories International, Inc. (NYSE: CRL) in the undefined quarter, according to its most recent filing with the Secu
Charles River Prepares to Report Q2 Earnings: What's in Store?
02:31pm, Thursday, 30'th Jul 2026
CRL is set to report Q2 results on Aug. 5 as investors watch segment demand, divestitures, and whether the company can extend its earnings beat streak.
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
11:01am, Wednesday, 29'th Jul 2026
Charles River (CRL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Epoch Investment Partners Inc. Sells 21,131 Shares of Charles River Laboratories International, Inc. $CRL
04:01am, Monday, 27'th Jul 2026
Epoch Investment Partners Inc. reduced its holdings in Charles River Laboratories International, Inc. (NYSE: CRL) by 77.0% during the first quarter, according to the company in its most recent 13F fil
Charles River Laboratories International Inc (CRL) Stock Up 4.8% but GF Value Says Overvalued -- GF Score: 70/100
06:41pm, Thursday, 23'rd Jul 2026
On July 23, 2026, Charles River Laboratories International Inc (CRL) shares rose 4.8% to a current price of $229.29. This movement marks a significant increase
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?
01:32pm, Tuesday, 21'st Jul 2026
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.
Fifth Third Bancorp Buys 6,002 Shares of Charles River Laboratories International, Inc. $CRL
04:03am, Tuesday, 21'st Jul 2026
Fifth Third Bancorp grew its stake in shares of Charles River Laboratories International, Inc. (NYSE: CRL) by 51.2% during the first quarter, according to the company in its most recent 13F filing wit
What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?
01:01pm, Friday, 17'th Jul 2026
Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Tuesday, 14'th Jul 2026
Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company,
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with Arovella Therapeutics Ltd (ASX: ALA), a biotechnology
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able
11:33am, Tuesday, 07'th Jul 2026
The last months were eventful for Achieve Life Sciences, sending the stock strongly down, but later to a new high for the year, implying optimism about the future path. Achieve is, in my view, a more
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
12:25pm, Friday, 03'rd Jul 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
LH or CRL: Which Is the Better Value Stock Right Now?
12:40pm, Wednesday, 01'st Jul 2026
Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for t
Is This the Right Time to Hold CRL Stock in Your Portfolio?
10:30am, Wednesday, 01'st Jul 2026
Charles River Laboratories International, Inc. CRL is well-poised to grow in the coming quarters owing to the strength of its Research Models and Services (“RMS”) business and broader CRADL adopt
